Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging

被引:96
|
作者
Ennis, DB
Epstein, FH
Kellman, P
Fananapazir, L
McVeigh, ER
Arai, AE
机构
[1] NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
[3] Univ Virginia, Dept Radiol, Charlottesville, VA USA
关键词
hypertrophy; cardiomyopathy; diastole; tagging; regional;
D O I
10.1002/mrm.10543
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Diastolic and systolic left ventricular (LV) dysfunction often significantly contribute to disabling symptoms in familial hypertrophic cardiomyopathy (FHC). This study compares regional LV function (midwall circumferential strain) during systole and diastole in eight FHC patients and six normal volunteers (NVs) using MR tagging. A prospectively-gated fast gradient-echo sequence with an echotrain readout was modified to support complementary spatial modulation of magnetization (CSPAMM) tagging and full cardiac cycle data acquisition using the cardiac phase to order reconstruction (CAPTOR), thus providing tag persistence and data acquisition during the entire cardiac cycle. Total systolic strains in FHC patients were significantly reduced in septal and inferior regions (both P < 0.01). Early-diastolic strain rates were reduced in all regions of the FHC group (all P < 0.03). The combination of CSPAMM and CAPTOR allows regional indices of myocardial function to be quantified throughout the cardiac cycle. This technique reveals regional differences in systolic and diastolic impairment in FHC patients. Published 2003 Wiley-Liss, Inc.
引用
收藏
页码:638 / 642
页数:5
相关论文
共 50 条
  • [41] Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy
    Beltrami, Matteo
    Bartolini, Simone
    Pastore, Maria Concetta
    Milli, Massimo
    Cameli, Matteo
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2022, 115 (11) : 598 - 609
  • [42] Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy
    Betocchi, S
    Piscione, F
    Losi, MA
    Pace, L
    Boccalatte, M
    PerroneFilardi, P
    CappelliBigazzi, M
    Briguori, C
    Manganelli, F
    Ciampi, Q
    Salvatore, M
    Chiariello, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (04): : 451 - 457
  • [43] FREQUENCY-DEPENDENT DIASTOLIC AND SYSTOLIC DYSFUNCTION OF THE LEFT-VENTRICLE IN HYPERTROPHIC CARDIOMYOPATHY - A RADIONUCLIDE ANGIOGRAPHIC STUDY
    NIENABER, C
    SPIELMANN, RP
    GEIGER, M
    KUNZE, KP
    KUCK, KH
    BLEIFELD, W
    ZEITSCHRIFT FUR KARDIOLOGIE, 1985, 74 : 73 - 73
  • [44] Differences in regional systolic and diastolic function by Doppler tissue imaging in patients with hypertrophic cardiomyopathy and hypertrophy caused by hypertension
    Nuñez, J
    Zamorano, JL
    De Isla, LP
    Palomeque, C
    Almeria, C
    Rodrigo, JL
    Corteza, J
    Banchs, J
    Macaya, C
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2004, 17 (07) : 717 - 722
  • [45] Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis
    Bergey, PD
    Axel, L
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (01) : 242 - 244
  • [46] ASSESSMENT OF THE MOLECULAR DEFECT IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    STRACESKI, AJ
    GEISTERFERLOWRANCE, A
    LOVE, T
    WATKINS, H
    SEIDMAN, CE
    SEIDMAN, JG
    LEINWAND, LA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 203 - 203
  • [47] ASSESSMENT OF THE MOLECULAR DEFECT IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    STRACESKI, AJ
    LOVE, T
    WATKINS, H
    SEIDMAN, CE
    SEIDMAN, JG
    LEINWAND, LA
    CIRCULATION, 1992, 86 (04) : 230 - 230
  • [48] The Effects of Systolic and Diastolic Dysfunction of Cirrhotic Cardiomyopathy in Liver Transplantation
    Buggs, Jacentha
    Shramek, Madison
    Rogers, Ebonie
    Kumar, Ambuj
    Kemmer, Nyingi
    AMERICAN SURGEON, 2018, 84 (11) : E464 - E466
  • [49] Tau as a predictor of cardiac events in cardiomyopathy with systolic and/or diastolic dysfunction
    Yokoi, T.
    Morimoto, R.
    Okumura, T.
    Yamaguchi, S.
    Kuwayama, T.
    Hiraiwa, H.
    Haga, T.
    Kondo, T.
    Sugiura, Y.
    Watanabe, N.
    Kano, N.
    Sawamura, A.
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1386 - 1387
  • [50] Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
    Cordts, Kathrin
    Seelig, Doreen
    Lund, Natalie
    Carrier, Lucie
    Boeger, Rainer H.
    Avanesov, Maxim
    Tahir, Enver
    Schwedhelm, Edzard
    Patten, Monica
    BIOMOLECULES, 2019, 9 (07)